A Q&A with Drs. Chengyu Liang and Meenhard Herlyn on skin cancer research at The Wistar Institute, including a few questions from melanoma survivors. Melanoma is the most aggressive form of ski…
Read some reflections from the Cheyney University students who participated in Wistar’s Biomedical Research Methods course during Spring 2022. Lights, lab coats, action! The click of pipettes and l…
The hybrid event marked the conclusion of the Institute’s Life Science Innovation Course that provides experience in biotechnology entrepreneurship. Students enrolled in The Wistar Institute’s…
For more than 20 years, The Wistar Institute has been training community college students with relevant, much-needed skills to attain in-demand jobs in the biomedical and biotechnology fields. Sinc…
In this virtual event held by the Chamber of Commerce, Wistar’s Associate Dean of Biomedical Studies Dr. David Zuzga spoke about workforce development and the value of apprenticeship programs at th…
Newly published research identifies a mutation associated with scarring of the lungs, revealing a useful diagnostic tool and target for gene therapy. Idiopathic pulmonary fibrosis (IPF) is a fatal …
Newly published research identifies proteins in EBV-infected cells that decreased expression of genes linked to the spread of the virus, a fresh direction for EBV research. Epstein-Barr virus is a …
Dr. Luis Montaner, Wistar’s Associate Director for Shared Resources, and Mark Drinker, Wistar’s Associate Director for Administration of the Ellen and Ronald Caplan Cancer Center, chat about core f…
From historic machinery in one of our own investigator’s personal collection to the modern technology transforming Wistar research today, microscopes have helped Wistar scientists and researchers a…
From HIV to COVID-19, Wistar scientists are at the forefront of vaccine development. Read our recap of the recent Vaccine Symposium and the impactful research in progress at the Institute. This pas…
